Showing 12 out of 2322 items
- CATIE NewsMontreal researchers conducted a 12-week study of cannabis extracts with 10 people with HIV. Cannabinoids appeared to reduce intestinal injury, inflammation and immune activation. A larger and longer…
- This document shares the most up-to-date community-preferred terminology related to cure research to help those presenting new research or sharing information with lay audiences.
- The aim of this spotlight report is to characterize trends in Fentanyl identifications across Canada since 2012 and draw a more comprehensive picture of Fentanyl in Canada based on exhibits seized…
- The aim of this spotlight report is to characterize trends in Xylazine identifications across Canada since 2012 and draw a more comprehensive picture of Xylazine in Canada based on exhibits seized…
- This protocol is intended to provide practical guidance for regulated and nonregulated health and social service providers to deliver eOPS to prevent and respond to drug poisoning in diverse settings…
- This brief reviews the evidence on supervised consumption sites, with a focus on effectiveness and community impact.
- The safer bathrooms toolkit provides a repository of potentially useful documents to assist with communication, training, policy and protocol development, and design to make bathrooms safer for…
- This tool will help to identify policies, and environmental and cultural factors that contribute to stigma and discrimination which affect individuals’ access to and use of available substance use…
- CATIE NewsFor over a decade, a study in Vancouver monitored 947 HIV-positive people who used drugs. People experiencing homelessness were at least 41% less likely to receive HIV treatment. Researchers…
- CATIE NewsResearchers enrolled 1,422 women living with HIV from British Columbia, Ontario and Quebec. Those who face stigma and discrimination were less likely to take medication as prescribed. The researchers…
- The purpose of this guidance is to provide policy recommendations for territorial, provincial and federal take-home naloxone programs.